TMEDvsIHEETF Comparison
VS
T. Rowe Price Health Care ETF (TMED) and iShares U.S. Pharmaceuticals ETF (IHE) belong to the same industry segment: US Health Care. TMED's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Non-Corporate. In contrast, IHE's top sector exposures are Healthcare and Non-Corporate. TMED is more expensive with a Total Expense Ratio (TER) of 0.44%, versus 0.37% for IHE. TMED is up 20.15% year-to-date (YTD) with +$13M in YTD flows. IHE performs better with 24.26% YTD performance, and +$599M in YTD flows. Run a side-by-side ETF comparison of TMED and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
TMED vs IHE performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/07/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | TMED IHE | +2.00%+3.47% | +13.61%+13.63% | +20.15%+24.26% | +38.54%+49.46% | n/a+75.18% | n/a+75.80% |
| Flows | TMED IHE | +$4M-$24M | +$10M+$607M | +$13M+$599M | +$15M+$756M | -+$848M | -+$853M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | TMED IHE | +17.62%+19.46% | +18.28%+18.11% | n/a+16.99% | n/a+16.57% |
| Max drawdown | TMED IHE | -4.40%-4.42% | -11.09%-8.48% | n/a-16.04% | n/a-16.12% |
| Max drawdown duration | TMED IHE | 31d20d | 125d81d | n/a210d | n/a669d |
Trading data
TMED | IHE | |
Last sale 9/8/2026 at 1:30 PM | $34.87 | $102.68 |
| Previous close 09/04/2026 | $35.65 | $104.68 |
| Consolidated volume 09/04/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
TMED
is actively managed and doesn’t replicate an indexTMED | IHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/8/2026 at 1:30 PM
Live
Closed
TMED | IHE | |
|---|---|---|
| Last price | $34.87 | $102.68 |
| 1D performance | -2.18% | -1.91% |
| AuM | $33.88 M | $1.67 B |
| E/R | 0.44% | 0.37% |
Characteristics
TMED | IHE | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | T. Rowe Price | iShares |
| Benchmark | - | Dow Jones U.S. Select Pharmaceuticals Index |
| N° of holdings | 97 | 57 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 11, 2025 | May 1, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
TMED
USA
93.59%
Other
6.41%
IHE
USA
95.81%
Other
4.19%
Sectors
TMED
Healthcare
98.58%
Other
1.42%
IHE
Healthcare
99.62%
Other
0.38%
Advertisement
Diversification
TMED
Total weight of top 15 holdings out of 15
61.11%
IHE
Total weight of top 15 holdings out of 15
84.32%
Top 15 holdings
Data as of July 31, 2026
TMED
Eli Lilly & Co.
16.65%
UnitedHealth Group, Inc.
5.89%
Thermo Fisher Scientific, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.11%
Gilead Sciences, Inc.
3.76%
Danaher Corp.
3.58%
Cencora, Inc.
3.30%
Insulet Corp.
2.73%
Agilent Technologies, Inc.
2.69%
DexCom, Inc.
2.66%
Dyne Therapeutics, Inc.
2.60%
Stryker Corp.
2.49%
West Pharmaceutical Services, Inc.
2.29%
Waters Corp.
2.20%
McKesson Corp.
1.72%
IHE
Johnson & Johnson
21.85%
Eli Lilly & Co.
20.71%
Bristol Myers Squibb Co.
4.75%
Viatris, Inc.
4.56%
Merck & Co., Inc.
4.44%
Royalty Pharma Plc
4.41%
Pfizer Inc.
3.96%
Zoetis, Inc.
3.81%
Jazz Pharmaceuticals Plc
3.58%
Elanco Animal Health, Inc.
2.92%
Corcept Therapeutics, Inc.
2.49%
Axsome Therapeutics, Inc.
2.24%
Crinetics Pharmaceuticals, Inc.
1.95%
Liquidia Corp.
1.35%
Ligand Pharmaceuticals, Inc.
1.31%
Frequently asked questions about TMED and IHE
How have the TMED and IHE ETFs performed in 2026?
As of September 7, 2026, TMED is up 20.15% year-to-date (YTD), while IHE has returned 24.26%. That puts IHE better performer ahead so far this year.
Which ETF is attracting more investor money: TMED or IHE?
Year-to-date, the TMED ETF saw +$13M in flows, compared to +$599M for IHE.
Which ETF is more volatile: TMED or IHE?
Over the past year, TMED had a volatility of 18.28%, while IHE experienced 18.11%.
Which ETF is bigger: TMED or IHE?
As of September 7, 2026, TMED holds $33.88 M in assets under management (AUM), while IHE manages $1.67 B.
What sectors do the TMED and IHE ETFs invest in?
TMED leans toward sectors like Healthcare. Meanwhile, IHE focuses on Healthcare.
What are the top holdings of the TMED ETF and IHE ETF?
TMED top holdings include Eli Lilly & Co., UnitedHealth Group, Inc. and Thermo Fisher Scientific, Inc.. IHE holds in its top three: Johnson & Johnson, Eli Lilly & Co. and Bristol Myers Squibb Co..
Which ETF is more diversified: TMED or IHE?
TMED holds 97 securities with 61.11% of its assets in the top 15. IHE has 57 securities and a top 15 weight of 84.32%.
Advertisement
Latest news about TMED & IHE
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
November 20, 2023
IHE
Healthcare Stocks Rebound
August 14, 2023
IHE
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IHE
Advertisement
Advertisement
